Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Convertible Debt came in at $2.1 million in Q4 2011.
Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011) Analysis & Trends
Tonix Pharmaceuticals Holding's Convertible Debt history runs 1 years deep, the most recent figure standing at $2.1 million for Q4 2011.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $2.1 million in Q4 2011; TTM through Dec 2011 was $2.1 million, a N/A change from a year earlier, with the FY2011 full-year figure at $2.1 million, changed N/A from the prior year.
- Convertible Debt was little changed at $2.1 million in Q4 2011 per TNXP's latest filing.
- Across five years, Convertible Debt topped out at $2.1 million in Q4 2011 and bottomed at $2.1 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Tonix Pharmaceuticals Holding | 141.32 Mn | 141.32 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 2.08 Mn |